Rappuoli, Rino

An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus

Traggiai, E., Becker, S., Subbarao, K., Kolesnikova, L., Uematsu, Y., Gismondo, M. R., Murphy, B. R., Rappuoli, R., & Lanzavecchia, A. (2004) · Nature Medicine

SARS-CoV-2 and COVID-19 ResearchMonoclonal and Polyclonal Antibodies Research

Cited by 697

Nonviral delivery of self-amplifying RNA vaccines

Geall, A. J., Verma, A., Otten, G. R., Shaw, C. A., Hekele, A., Banerjee, K., Cu, Y., Beard, C. W., Brito, L. A., Krucker, T., et al. (2012) · Proceedings of the National Academy of Sciences

RNA Interference and Gene DeliveryImmunotherapy and Immune Responses

Cited by 675

Identification of a Universal Group B Streptococcus Vaccine by Multiple Genome Screen

Maione, D., Margarit, I., Rinaudo, C. D., Masignani, V., Mora, M., Scarselli, M., Tettelin, H., Brettoni, C., Iacobini, E. T., Rosini, R., et al. (2005) · Science

Neonatal and Maternal InfectionsBacterial Infections and Vaccines

Cited by 556

A novel glyco-conjugate vaccine against fungal pathogens

Torosantucci, A., Bromuro, C., Chiani, P., De Bernardis, F., Berti, F., Galli, C., Norelli, F., Bellucci, C., Polonelli, L., Costantino, P., et al. (2005) · The Journal of Experimental Medicine

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 442

Vaccines for the twenty-first century society

Rappuoli, R., Mandl, C. W., Black, S., & De Gregorio, E. (2011) · Nature Reviews Immunology

Immune responses and vaccinationsImmunotherapy and Immune Responses

Cited by 388

Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers

Swanson, K. A., Settembre, E. C., Shaw, C. A., Dey, A. K., Rappuoli, R., Mandl, C. W., Dormitzer, P. R., & Carfi, A. (2011) · Proceedings of the National Academy of Sciences

Respiratory viral infections researchSARS-CoV-2 and COVID-19 Research

Cited by 285

Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coli

Moriel, D. G., Bertoldi, I., Spagnuolo, A., Marchi, S., Rosini, R., Nesta, B., Pastorello, I., Corea, V. A. M., Torricelli, G., Cartocci, E., et al. (2010) · Proceedings of the National Academy of Sciences

Escherichia coli research studiesvaccines and immunoinformatics approaches

Cited by 261

Helicobacter pylori cytotoxin-associated gene A (CagA) subverts the apoptosis-stimulating protein of p53 (ASPP2) tumor suppressor pathway of the host

Buti, L., Spooner, E., Van der Veen, A. G., Rappuoli, R., Covacci, A., & Ploegh, H. L. (2011) · Proceedings of the National Academy of Sciences

Helicobacter pylori-related gastroenterology studiesCancer-related Molecular Pathways

Cited by 253

Rapidly produced SAM ® vaccine against H7N9 influenza is immunogenic in mice

Hekele, A., Bertholet, S., Archer, J., Gibson, D. G., Palladino, G., Brito, L. A., Otten, G. R., Brazzoli, M., Buccato, S., Bonci, A., et al. (2013) · Emerging Microbes & Infections

Influenza Virus Research StudiesRNA Interference and Gene Delivery

Cited by 226

Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines

Walls, A. C., Miranda, M. C., Schäfer, A., Pham, M. N., Greaney, A., Arunachalam, P. S., Navarro, M.-J., Tortorici, M. A., Rogers, K., O’Connor, M. A., et al. (2021) · Cell

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies

Cited by 185

Structural vaccinology starts to deliver

Dormitzer, P. R., Grandi, G., & Rappuoli, R. (2012) · Nature Reviews Microbiology

vaccines and immunoinformatics approachesEnzyme Structure and Function

Cited by 143

Microbial genomes and vaccine design: refinements to the classical reverse vaccinology approach

Mora, M., Donati, C., Medini, D., Covacci, A., & Rappuoli, R. (2006) · Current Opinion in Microbiology

vaccines and immunoinformatics approachesGenomics and Phylogenetic Studies

Cited by 92

Emerging experience with meningococcal serogroup B protein vaccines

Toneatto, D., Pizza, M., Masignani, V., & Rappuoli, R. (2017) · Expert Review of Vaccines

Bacterial Infections and VaccinesMicrobial infections and disease research

Cited by 67

Licensed H5N1 vaccines generate cross-neutralizing antibodies against highly pathogenic H5N1 clade 2.3.4.4b influenza virus

Khurana, S., King, L. R., Manischewitz, J., Posadas, O., Mishra, A. K., Liu, D., Beigel, J. H., Rappuoli, R., Tsang, J. S., & Golding, H. (2024) · Nature Medicine

Influenza Virus Research StudiesVirology and Viral Diseases

Cited by 57